DURAFLAME INJ 3ML
— Product

DURAFLAME INJ 3ML

DICLO 25MG 3ML INJ

DURAFLAME INJ 3ML is an injection of diclofenac 25 mg per ml in a 3 ml presentation, given by deep intramuscular injection. It is used for acute severe pain — renal and biliary colic, acute musculoskeletal injury, post-operative pain and acute arthritic flares — where rapid analgesia is needed.

01

Benefits

  • Rapid onset by injection for severe acute pain where an oral dose would act too slowly.
  • Highly effective in renal colic, where NSAIDs relieve pain and reduce ureteric smooth muscle activity.
  • Useful post-operatively as part of a multimodal regimen, reducing opioid requirement.
  • The 3 ml presentation allows dose flexibility for the prescriber.
  • Provides potent anti-inflammatory as well as analgesic effect in acute arthritic flares.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Pain or induration at the injection site
  • Nausea or epigastric discomfort
  • Dizziness or headache
  • Drowsiness
Less common
  • Gastric erosion or bleeding
  • Rise in blood pressure or fluid retention
  • Raised liver enzymes
  • Skin rash or itching
Stop and get medical help if any of these occur
  • Black, tarry stools or vomiting of blood
  • Chest pain, breathlessness, or weakness or numbness down one side
  • Swelling of the face, lips or tongue, or difficulty breathing
  • A marked fall in urine output
  • Severe pain, redness or swelling at the injection site
03

Precautions

  • For administration by a qualified healthcare professional, by deep intramuscular injection into the upper outer quadrant of the buttock.
  • Contraindicated in established ischaemic heart disease, cerebrovascular disease, peripheral arterial disease and moderate to severe heart failure.
  • Contraindicated in active peptic ulcer disease or a history of gastrointestinal bleeding.
  • Contraindicated in severe hepatic or renal impairment, and in NSAID hypersensitivity including aspirin-sensitive asthma.
  • Contraindicated in the third trimester of pregnancy.
  • Limit to the shortest course possible before switching to an oral route.
  • Ensure adequate hydration; NSAID-related renal injury is far more likely in a volume-depleted patient.
  • Do not give alongside another NSAID.